VERICEL CORPORATION Inventory
VERICEL CORPORATION (VCEL) had Inventory of $18.38 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-07-30
- 2026-06-30: Inventory, Net $18.38M.
- 2026-03-31: Inventory, Net $18.35M.
- 2025-12-31: Inventory, Net $17.56M.
- 2025-09-30: Inventory, Net $18.16M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $18.38M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $18.35M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $17.56M 10-Q · filed 2026-07-30 |
| 2025-09-30 | $18.16M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $16.83M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $17.11M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $17.37M 10-K · filed 2026-02-26 |
| 2024-09-30 | $15.76M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $14.89M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $13.56M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $13.09M 10-K · filed 2025-02-27 |
| 2023-09-30 | $12.62M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $13.88M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $15.37M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $15.99M 10-K · filed 2024-02-29 |
| 2022-09-30 | $16.73M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $15.93M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $14.38M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $13.38M 10-K · filed 2023-02-23 |
| 2021-09-30 | $13.06M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $12.96M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $10.32M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $9.36M 10-K · filed 2022-02-24 |
| 2020-09-30 | $10.08M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $8.42M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $7.28M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $6.82M 10-K · filed 2021-02-24 |
| 2019-09-30 | $6.82M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $4.79M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $4.06M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $3.56M 10-K · filed 2020-02-25 |
| 2018-09-30 | $3.64M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $3.73M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $3.90M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $3.79M 10-K · filed 2019-02-26 |
| 2017-09-30 | $4.05M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $3.15M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $3.96M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.49M 10-K · filed 2018-03-05 |
| 2016-09-30 | $3.61M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $2.39M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $1.94M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.38M 10-K · filed 2017-03-13 |
| 2015-09-30 | $1.64M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $2.08M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $2.00M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $1.92M 10-K · filed 2016-03-14 |
| 2014-09-30 | $1.71M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.92M 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |